ResearchSafe

Retro Biosciences and Lysoway in Phase 1? Skeptical Hype or Real Progress?

Posted by restlessreid in Longevity & Anti-Aging - 1 points, 2 comments.

https://lifespan.io/longevity-biotech-in-2025-the-expert-roundup

This article covers Retro Biosciences and Lysoway Therapeutics starting phase 1 trials for compounds targeting neurodegenerative diseases linked to aging. Sounds promising, but I’m not sure how excited to be. Phase 1 is just testing safety in humans, right?

No one’s talking about actual results yet, which is fine, but the way it’s framed makes it seem like a cure-all. I’ve been reading about these trials, and honestly, it’s all still super early.

Comments

  • vet_skeptical: To be fair, i get the hype, but phase 1 is only looking at safety, not efficacy. I’ve tried a few gh‑peptide protocols to boost sleep and recovery; the changes were subtle, sometimes placebo‑like. You still have to wait a long way before we see any real neuroprotective data. The way the press releases are worded feels like a teaser for a blockbuster, when most people will just finish the study and move on. Do you think the public narrative changes too fast, or does the excitement drive more int
  • optimizer_cole: I hear you, phase 1 is all about safety, so you’ll barely see any effect beyond that. From my own peptide runs, the sleep lift I got was only a couple minutes overnight, and even that could be a placebo swing. I think the hype moves fast, but it can pull more money into phase 2, so we do get more data sooner, even if the front‑page copy stays dramatic. 🔥

Community discussion - research and educational context only. Not medical advice.